Tag - therapeutics

Invert launches Invert Assist, an AI-powered analysis interface built for bioprocess

SCIMap: View Impact of Federal Health Research Cuts

TLDR; The Value of Drugs for Rare Disease Indications May Be Higher Than You Think – Assets for Neurodevelopmental Disorders Alone May Be Worth Beyond USD $420B.

Novel Genetic Priority Score (GPS) Unveiled to Enhance Target Prioritization in Drug Development

The Role of the Human Gut Microbiome in Alzheimer’s Disease Development

Velsera Is Building an Ecosystem that Accelerates the R&D Loop and Democratizes Omics Data to Propel the Next Era of Precision Medicine

Deepcell Aims to Create a Single Cell Morpholome Platform

Enlightenbio Releases New Report – Database of Biomarkers Curated from US Oncology Trials

Illumina and Genetic Alliance Launch $120 Million Global Initiative to Increase Equity and Improve Outcomes for Families Impacted by Genetic Disease

FAIR Data or the Journey Towards Data-Centricity – Pushing Towards Making Data Discoverable, Accessible, Interoperable, and Reusable

Seven Bridges Announces Initial Close of Series C Funding from New Strategic Investor to Accelerate Product Development and Commercial Growth

Genomics plc completes oversubscribed $30M funding round

Tempus Launches Hereditary Cancer Germline Assay, xG

Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle

My Gene Counsel and Genomet Announce Product Partnership to Transform Cancer Care Around the Globe

UK Biobank launches one of the largest scientific studies measuring circulating proteins, to better understand the link between genetics and human disease

Copyright © 2026. enlighenbio LLC. All rights reserved.